.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Medtronic
Fuji
Daiichi Sankyo
Novartis
QuintilesIMS
Farmers Insurance
Chinese Patent Office
Teva
Accenture

Generated: September 20, 2017

DrugPatentWatch Database Preview

Technetium tc-99m red blood cell kit - Generic Drug Details

« Back to Dashboard

What are the generic sources for technetium tc-99m red blood cell kit and what is the scope of technetium tc-99m red blood cell kit patent protection?

Technetium tc-99m red blood cell kit
is the generic ingredient in two branded drugs marketed by Cadema and Mallinkrodt Nuclear, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m red blood cell kit. One supplier is listed for this compound.

Summary for Generic Name: technetium tc-99m red blood cell kit

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list4
Suppliers / Packagers: see list1
Clinical Trials: see list33,738
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:technetium tc-99m red blood cell kit at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
ULTRATAG
technetium tc-99m red blood cell kit
INJECTABLE;INJECTION019981-001Jun 10, 1991RXNoNo► Subscribe► Subscribe► Subscribe
Cadema
RBC-SCAN
technetium tc-99m red blood cell kit
INJECTABLE;INJECTION020063-001Jun 11, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: technetium tc-99m red blood cell kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear
ULTRATAG
technetium tc-99m red blood cell kit
INJECTABLE;INJECTION019981-001Jun 10, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Deloitte
Express Scripts
McKinsey
Harvard Business School
Medtronic
Fuji
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot